548
Views
23
CrossRef citations to date
0
Altmetric
Critical Care

‘Ivory wave’ toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning

, , , , , , , , , & show all
Pages 108-113 | Received 15 Oct 2011, Accepted 02 Dec 2011, Published online: 06 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

D. M. Wood, F. Heyerdahl, C. B. Yates, A. M. Dines, I. Giraudon, K. E. Hovda & P. I. Dargan. (2014) The European Drug Emergencies Network (Euro-DEN). Clinical Toxicology 52:4, pages 239-241.
Read now

Articles from other publishers (21)

María Espinosa-Velasco, Marina D. Reguilón, Marina Bellot, Núria Nadal-Gratacós, Xavier Berzosa, Cristian Gómez-Canela, Marta Rodríguez-Arias, Jordi Camarasa, Elena Escubedo, David Pubill & Raúl López-Arnau. (2022) Repeated administration of N-ethyl-pentedrone induces increased aggression and impairs social exploration after withdrawal in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 117, pages 110562.
Crossref
María Espinosa‐Velasco, Marina D. Reguilón, Marina Bellot, Núria Nadal‐Gratacós, Xavier Berzosa, Pol Puigseslloses, Cristian Gómez‐Canela, Marta Rodríguez‐Arias, David Pubill, Jordi Camarasa, Elena Escubedo & Raúl López‐Arnau. (2021) Behavioural and neurochemical effects after repeated administration of N‐ethylpentylone (ephylone) in mice. Journal of Neurochemistry 160:2, pages 218-233.
Crossref
John R.H. Archer. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 131 156 .
Dong-Hyun Youn, Jin Mook Kim, Young-ki Hong, Seo-In Park, Jin-Moo Lee, Young-Hoon Kim, Chang Won Park & Mi Sun Kang. (2021) Assessment of the abuse potential of methamnetamine in rodents: a behavioral pharmacology study. Psychopharmacology 238:8, pages 2155-2165.
Crossref
Hye Jin Cha, Jin Mook Kim, Young-Hsoon Kim & Soo Kyung Suh. (2019) Rewarding effects of 2-desoxypipradrol in mice. Neuroscience Letters 705, pages 46-50.
Crossref
Janice Pettie, Allan Burt, Duleeka W. Knipe, Hazel Torrance, Margaret Dow, Karen Osinski, Robert Greig, Diletta Sabatini, Kate Easterford, James Dear & Michael Eddleston. (2018) New drug controls and reduced hospital presentations due to novel psychoactive substances in Edinburgh. British Journal of Clinical Pharmacology 84:10, pages 2303-2310.
Crossref
Andrew King, Mirjana Dimovska & Luke Bisoski. (2018) Sympathomimetic Toxidromes and Other Pharmacological Causes of Acute Hypertension. Current Hypertension Reports 20:1.
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Elisabeth Leere Øiestad, Åse Marit Leere Øiestad, Astrid Gjelstad & Ritva Karinen. (2016) Oral fluid drug analysis in the age of new psychoactive substances. Bioanalysis 8:7, pages 691-710.
Crossref
Laura Hondebrink, Johanna J. Nugteren-van Lonkhuyzen, Daan Van Der Gouwe & Tibor M. Brunt. (2015) Monitoring new psychoactive substances (NPS) in The Netherlands: Data from the drug market and the Poisons Information Centre. Drug and Alcohol Dependence 147, pages 109-115.
Crossref
Elena Durán, Marta Mosquera, Cristina Ruiz, Fernando Bandrés, Francesc Campos, Bartomeu Castanyer, Carme Farré, Juan Fernando Izquierdo, Elena Llorente, Jordi To-Figueras, Salvador Ventura & Josep M. Queraltó. (2015) Desoxipipradrol. Fármacos antiguos, problemas nuevos. Revista del Laboratorio Clínico 8:1, pages 29-38.
Crossref
D. M. Wood, S. L. Hill, S. H. L. Thomas & P. I. Dargan. (2014) Using poisons information service data to assess the acute harms associated with novel psychoactive substances. Drug Testing and Analysis 6:7-8, pages 850-860.
Crossref
Linda D. Simmler, Anna Rickli, York Schramm, Marius C. Hoener & Matthias E. Liechti. (2014) Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives. Biochemical Pharmacology 88:2, pages 237-244.
Crossref
Raimondo Bruno, Rosalie Poesiat & Allison Jane Matthews. (2013) Monitoring the Internet for emerging psychoactive substances available to Australia. Drug and Alcohol Review, pages n/a-n/a.
Crossref
Donata Favretto, Jennifer P. Pascali & Franco Tagliaro. (2013) New challenges and innovation in forensic toxicology: Focus on the “New Psychoactive Substances”. Journal of Chromatography A 1287, pages 84-95.
Crossref
Markus R. Meyer, Sara Schmitt & Hans H. Maurer. (2013) Studies on the metabolism and detectability of the emerging drug of abuse diphenyl‐2‐pyrrolidinemethanol (D2PM) in rat urine using GC‐MS and LC‐HR‐MS/MS. Journal of Mass Spectrometry 48:2, pages 243-249.
Crossref
Bénédicte Lelièvre, Séverine Férec, David Boels, Mohammed Bennaceur, Patrick Harry, Chadi Abbara, Bertrand Diquet & Alain Turcant. (2013) Le désoxypipradrol, une nouvelle drogue disponible sur Internet : à propos d’un cas. Annales de Toxicologie Analytique 25:2, pages 57-62.
Crossref
Michael W. White & John R.H. Archer. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances 233 259 .
John M. Corkery, Simon Elliott, Fabrizio Schifano, Ornella Corazza & A. Hamid Ghodse. (2012) 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 39:2, pages 253-258.
Crossref
M. Coppola & R. Mondola. (2012) Research chemicals marketed as legal highs: The case of pipradrol derivatives. Toxicology Letters 212:1, pages 57-60.
Crossref
D N Bateman. (2012) Poisoning and self-harm. Clinical Medicine 12:3, pages 280-282.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.